This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chan, O. Articles by Matthews, S. G. Search for Related Content PubMed PubMed Citation Articles by Chan, O. Articles by Matthews, S. G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Molecular Regulation of the Hypothalamo-Pituitary-Adrenal Axis in Streptozotocin-Induced Diabetes: Effects of Insulin Treatment

Departments of Physiology (O.C., S.C., K.I., M.V., S.G.M.), Obstetrics and Gynecology (S.G.M.), and Medicine (M.V.), University of Toronto, Toronto, Ontario, Canada M5S 1A8

Address all correspondence and requests for reprints to: Dr. Stephen G Matthews, 1 King’s College Circle, Medical Sciences Building, Room 3240, University of Toronto, Toronto, Ontario, Canada M5S 1A8. E-mail: stephen.matthews{at}utoronto.ca

Increased hypothalamo-pituitary-adrenocortical (HPA) activity in diabetes is likely important in the development of some pathologies associated with the disorder. We hypothesized that central regulation of HPA activity differs among normal, streptozotocin (STZ)-diabetic, and insulin-treated diabetic rats. Blood glucose, ACTH, and corticosterone were elevated, 8 d after inducing diabetes. Insulin treatment normalized these parameters. Plasma norepinephrine was similar in all groups, but epinephrine was lower in STZ-diabetic and higher in insulin-treated rats vs. normals. Increased ACTH with diabetes corresponded with increased hypothalamic CRH mRNA, but no change in pituitary POMC mRNA. With insulin-treatment, CRH mRNA remained elevated, and POMC mRNA was unaltered. Hippocampal MR mRNA expression was dramatically increased with diabetes and, moreover, was not normalized by insulin. No differences in GR mRNA were detected between normal and STZ-diabetic rats. However, insulin treatment increased GR mRNA levels in the paraventricular nucleus and pituitary. We postulate that, in STZ-diabetes: 1) increased HPA activity is caused by increased central drive at and/or above the level of the paraventricular nucleus and is associated with decreased epinephrine; and 2) normalized pituitary-adrenal activity with insulin may be caused by the compensatory increase in GR mRNA allowing glucocorticoid-mediated suppression of ACTH secretion despite the residual increase in central HPA activity. Thus, insulin apparently restored HPA activity at and below the pituitary but, surprisingly, not above it.

This article has been cited by other articles:

				Y. Tozuka, E. Wada, and K. Wada Diet-induced obesity in female mice leads to peroxidized lipid accumulations and impairment of hippocampal neurogenesis during the early life of their offspring FASEB J, June 1, 2009; 23(6): 1920 - 1934. [Abstract] [Full Text] [PDF]

				Y. Revsin, D. van Wijk, F. E. Saravia, M. S. Oitzl, A. F. De Nicola, and E. R. de Kloet Adrenal Hypersensitivity Precedes Chronic Hypercorticism in Streptozotocin-Induced Diabetes Mice Endocrinology, July 1, 2008; 149(7): 3531 - 3539. [Abstract] [Full Text] [PDF]

				H. E. Bates, A. S. Sirek, M. A. Kiraly, J. T. Y. Yue, D. Goche Montes, S. G. Matthews, and M. Vranic Adaptation to Mild, Intermittent Stress Delays Development of Hyperglycemia in the Zucker Diabetic Fatty Rat Independent of Food Intake: Role of Habituation of the Hypothalamic-Pituitary-Adrenal Axis Endocrinology, June 1, 2008; 149(6): 2990 - 3001. [Abstract] [Full Text] [PDF]

				K. Bedard, J. Strecko, K. Theriault, J. Bedard, C. Veyrat-Durebex, and P. Gaudreau Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E740 - E751. [Abstract] [Full Text] [PDF]

				A. P. W. Johnston, J. E. Campbell, J. G. Found, M. C. Riddell, and T. J. Hawke Streptozotocin induces G2 arrest in skeletal muscle myoblasts and impairs muscle growth in vivo Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1033 - C1040. [Abstract] [Full Text] [PDF]

				Q. Huang, E. Timofeeva, and D. Richard Corticotropin-releasing factor and its receptors in the brain of rats with insulin and corticosterone deficits. J. Mol. Endocrinol., October 1, 2006; 37(2): 213 - 226. [Abstract] [Full Text] [PDF]

				D. Zelena, L. Filaretova, Z. Mergl, I. Barna, Z. E. Toth, and G. B. Makara Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E243 - E250. [Abstract] [Full Text] [PDF]

				E. Park, O. Chan, Q. Li, M. Kiraly, S. G. Matthews, M. Vranic, and M. C. Riddell Changes in basal hypothalamo-pituitary-adrenal activity during exercise training are centrally mediated Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1360 - R1371. [Abstract] [Full Text] [PDF]

				O. Chan, K. Inouye, E. M. Akirav, E. Park, M. C. Riddell, S. G. Matthews, and M. Vranic Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R235 - R246. [Abstract] [Full Text] [PDF]

				O. Chan, K. Inouye, E. Akirav, E. Park, M. C. Riddell, M. Vranic, and S. G. Matthews Insulin Alone Increases Hypothalamo-Pituitary-Adrenal Activity, and Diabetes Lowers Peak Stress Responses Endocrinology, March 1, 2005; 146(3): 1382 - 1390. [Abstract] [Full Text] [PDF]

				K. E. Inouye, O. Chan, J. T. Y. Yue, S. G. Matthews, and M. Vranic Effects of diabetes and recurrent hypoglycemia on the regulation of the sympathoadrenal system and hypothalamo-pituitary-adrenal axis Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E422 - E429. [Abstract] [Full Text] [PDF]

				D. A. Sandoval, L. Ping, R. A. Neill, B. Gong, K. Walsh, and S. N. Davis Brain region-dependent effects of dexamethasone on counterregulatory responses to hypoglycemia in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R413 - R419. [Abstract] [Full Text] [PDF]

				G. N. Neigh, S. L. Bowers, L. M. Pyter, M. L. Gatien, and R. J. Nelson Pyruvate Prevents Restraint-Induced Immunosuppression via Alterations in Glucocorticoid Responses Endocrinology, September 1, 2004; 145(9): 4309 - 4319. [Abstract] [Full Text] [PDF]

				O. Chan, S. Chan, K. Inouye, K. Shum, S. G. Matthews, and M. Vranic Diabetes Impairs Hypothalamo-Pituitary-Adrenal (HPA) Responses to Hypoglycemia, and Insulin Treatment Normalizes HPA but not Epinephrine Responses Diabetes, June 1, 2002; 51(6): 1681 - 1689. [Abstract] [Full Text] [PDF]

				K. Inouye, K. Shum, O. Chan, J. Mathoo, S. G. Matthews, and M. Vranic Effects of recurrent hyperinsulinemia with and without hypoglycemia on counterregulation in diabetic rats Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1369 - E1379. [Abstract] [Full Text] [PDF]

				O. Chan, K. Inouye, M. Vranic, and S. G. Matthews Hyperactivation of the Hypothalamo-Pituitary-Adrenocortical Axis in Streptozotocin-Diabetes Is Associated with Reduced Stress Responsiveness and Decreased Pituitary and Adrenal Sensitivity Endocrinology, May 1, 2002; 143(5): 1761 - 1768. [Abstract] [Full Text] [PDF]